{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:14:22Z","timestamp":1792782862382,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Special Account for Research Grants (SARG), National and Kapodistrian University of Athens","award":["0794"],"award-info":[{"award-number":["0794"]}],"id":[{"id":"https:\/\/ror.org\/04gnjpq42","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10067-026-08344-z","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T09:37:04Z","timestamp":1787218624000},"page":"6181-6187","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circulating levels of TL1A and its decoy receptor DcR3 in systemic sclerosis"],"prefix":"10.1007","volume":"45","author":[{"given":"Vassiliki","family":"Poulia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos I.","family":"Vlachogiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini-Paraskevi","family":"Avdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki-Kalliopi","family":"Bournia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Bamias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"Tektonidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros P.","family":"Sfikakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3720-5996","authenticated-orcid":false,"given":"Stylianos","family":"Panopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"8344_CR1","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D (2017) Systemic sclerosis. Lancet 390:1685\u20131699","journal-title":"Lancet"},{"key":"8344_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/annrheumdis-2020-217455","volume":"80","author":"AM Hoffmann-Vold","year":"2021","unstructured":"Hoffmann-Vold AM, Allanore Y, Alves M et al (2021) Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database. Ann Rheum Dis 80:219\u2013227. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217455","journal-title":"Ann Rheum Dis"},{"key":"8344_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-001694","author":"VK Bournia","year":"2021","unstructured":"Bournia VK, Fragoulis GE, Mitrou P et al (2021) All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015-2019. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2021-001694","journal-title":"RMD Open"},{"key":"8344_CR4","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1136\/ard.2009.114264","volume":"69","author":"AJ Tyndall","year":"2010","unstructured":"Tyndall AJ, Bannert B, Vonk M et al (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69:1809\u20131815. https:\/\/doi.org\/10.1136\/ard.2009.114264","journal-title":"Ann Rheum Dis"},{"key":"8344_CR5","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","volume":"76","author":"M Elhai","year":"2017","unstructured":"Elhai M, Meune C, Boubaya M et al (2017) Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis 76:1897\u20131905. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211448","journal-title":"Ann Rheum Dis"},{"key":"8344_CR6","unstructured":"Migone TS,\u00a0Jun Zhang,\u00a0Xia Luo et al (2002) TL1A first description and function_Immunity"},{"key":"8344_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/JIR.S546272","volume":"19","author":"K Kitsou","year":"2026","unstructured":"Kitsou K, Kokkotis G, Bamias G (2026) The therapeutic potential of targeting TL1A in a spectrum of inflammatory disorders. J Inflamm Res 19:1\u201325","journal-title":"J Inflamm Res"},{"key":"8344_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semarthrit.2015.02.007","volume":"45","author":"SI Siakavellas","year":"2015","unstructured":"Siakavellas SI, Sfikakis PP, Bamias G (2015) The TL1A\/DR3\/DcR3 pathway in autoimmune rheumatic diseases. Semin Arthritis Rheum 45:1\u20138","journal-title":"Semin Arthritis Rheum"},{"key":"8344_CR9","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.4049\/jimmunol.2000665","volume":"205","author":"R Herro","year":"2020","unstructured":"Herro R, Miki H, Sethi GS et al (2020) TL1A promotes lung tissue fibrosis and airway remodeling. J Immunol 205:2414\u20132422. https:\/\/doi.org\/10.4049\/jimmunol.2000665","journal-title":"J Immunol"},{"key":"8344_CR10","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/25387","volume":"396","author":"RM Pitti","year":"1998","unstructured":"Pitti RM, Marsters SA, Lawrence DA et al (1998) Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 396:699\u2013703. https:\/\/doi.org\/10.1038\/25387","journal-title":"Nature"},{"key":"8344_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/path.4749","volume":"240","author":"J Im","year":"2016","unstructured":"Im J, Kim K, Hergert P et al (2016) Idiopathic pulmonary fibrosis fibroblasts become resistant to Fas ligand-dependent apoptosis via the alteration of decoy receptor 3. J Pathol 240:25\u201337. https:\/\/doi.org\/10.1002\/path.4749","journal-title":"J Pathol"},{"key":"8344_CR12","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F Van Den Hoogen","year":"2013","unstructured":"Van Den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against rheumatism collaborative initiative. Arthritis Rheum 65:2737\u20132747. https:\/\/doi.org\/10.1002\/art.38098","journal-title":"Arthritis Rheum"},{"key":"8344_CR13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/annrheumdis-2016-209768","volume":"76","author":"G Valentini","year":"2017","unstructured":"Valentini G, Iudici M, Walker UA et al (2017) The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index. Ann Rheum Dis 76:270\u2013276. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209768","journal-title":"Ann Rheum Dis"},{"key":"8344_CR14","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/art.43120","volume":"77","author":"S Di Donato","year":"2025","unstructured":"Di Donato S, Ross R, Karanth R et al (2025) Serum type I interferon score for prediction of clinically meaningful disease progression in limited cutaneous systemic sclerosis. Arthritis Rheum 77:929\u2013941. https:\/\/doi.org\/10.1002\/art.43120","journal-title":"Arthritis Rheum"},{"key":"8344_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1684\/ejd.2012.1702","volume":"22","author":"D Yamada","year":"2012","unstructured":"Yamada D, Asano Y, Takahashi T et al (2012) Clinical significance of serum decoy receptor 3 levels in patients with systemic sclerosis. Eur J Dermatol 22:351\u2013357. https:\/\/doi.org\/10.1684\/ejd.2012.1702","journal-title":"Eur J Dermatol"},{"key":"8344_CR16","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s10067-017-3612-y","volume":"36","author":"W Xu","year":"2017","unstructured":"Xu W, Su L, Qing P et al (2017) Elevated levels of TL1A are associated with disease activity in patients with systemic sclerosis. Clin Rheumatol 36:1317\u20131324. https:\/\/doi.org\/10.1007\/s10067-017-3612-y","journal-title":"Clin Rheumatol"},{"key":"8344_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.clim.2008.07.014","volume":"129","author":"G Bamias","year":"2008","unstructured":"Bamias G, Siakavellas SI, Stamatelopoulos KS et al (2008) Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis. Clin Immunol 129:249\u2013255. https:\/\/doi.org\/10.1016\/j.clim.2008.07.014","journal-title":"Clin Immunol"},{"key":"8344_CR18","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/rheumatology\/kes316","volume":"52","author":"M Konsta","year":"2013","unstructured":"Konsta M, Bamias G, Tektonidou MG et al (2013) Increased levels of soluble TNF-like cytokine 1A in ankylosing spondylitis. Rheumatology (United Kingdom) 52:448\u2013451. https:\/\/doi.org\/10.1093\/rheumatology\/kes316","journal-title":"Rheumatology (United Kingdom)"},{"key":"8344_CR19","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/modpathol.2013.29","volume":"26","author":"WC Tseng","year":"2013","unstructured":"Tseng WC, Yang WC, Yang AH et al (2013) Expression of TNFRSF6B in kidneys is a novel predictor for progression of chronic kidney disease. Mod Pathol 26:984\u2013994. https:\/\/doi.org\/10.1038\/modpathol.2013.29","journal-title":"Mod Pathol"},{"key":"8344_CR20","doi-asserted-by":"crossref","unstructured":"Liu Y-P, Zhu H-F, Liu D-L, et al (2016) DcR3 induces epithelial-mesenchymal transition through activation of the TGF-\u03b23\/SMAD signaling pathway in CRC","DOI":"10.18632\/oncotarget.12639"},{"key":"8344_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-026-09152-8","author":"J Sia","year":"2026","unstructured":"Sia J, Lee B, Oon HH (2026) Therapeutic potential of tulisokibart and anti-TL1A therapy in inflammatory disorders: current insights and future directions. Clin Rev Allergy Immunol. https:\/\/doi.org\/10.1007\/s12016-026-09152-8","journal-title":"Clin Rev Allergy Immunol"},{"key":"8344_CR22","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.autrev.2018.02.008","volume":"17","author":"S Panopoulos","year":"2018","unstructured":"Panopoulos S, Bournia VK, Konstantonis G et al (2018) Predictors of morbidity and mortality in early systemic sclerosis: long-term follow-up data from a single-centre inception cohort. Autoimmun Rev 17:816\u2013820","journal-title":"Autoimmun Rev"},{"key":"8344_CR23","doi-asserted-by":"publisher","first-page":"7775","DOI":"10.3390\/cimb45100490","volume":"45","author":"G Di Maggio","year":"2023","unstructured":"Di Maggio G, Confalonieri P, Salton F et al (2023) Biomarkers in systemic sclerosis: an overview. Curr Issues Mol Biol 45:7775\u20137802","journal-title":"Curr Issues Mol Biol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08344-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08344-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08344-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:05:05Z","timestamp":1789545905000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08344-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["8344"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08344-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"14 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}}]}}